The women who received GnRH-ant pretreatment achieved higher high-quality embryo rates and improved oocyte quality, normal fertilization rate and high-quality embryo rate without increasing the cycle cancelation rate nor the incidence of OHSS. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.